📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Frailty in randomized controlled trials of glucose-lowering therapies for type 2 diabetes: An individual participant data meta-analysis of frailty prevalence, treatment efficacy, and adverse events (2025)

First Author: Wightman H

Attributed to: Real-world treatment effectiveness in people with type 2 diabetes: Maximising the applicability of clinical trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pmed.1004553

PubMed Identifier: 40193407

Publication URI: http://europepmc.org/abstract/MED/40193407

Type: Journal Article/Review

Parent Publication: PLOS Medicine

Issue: 4

ISSN: 1549-1277